Published in Cochrane Database Syst Rev on January 25, 2005
The Role of Exercise in Modifying Outcomes for People With Multiple Sclerosis (MStep) | NCT01611987
The benefits of exercise training in multiple sclerosis. Nat Rev Neurol (2012) 1.21
Perceived needs and satisfaction with care in people with multiple sclerosis: a two-year prospective study. BMC Neurol (2008) 1.05
Rehabilitation interventions in multiple sclerosis: an overview. J Neurol (2012) 1.04
Variations in functioning and disability in multiple sclerosis. A two-year prospective study. J Neurol (2008) 1.03
Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis. J Neurol (2011) 0.97
Meta-analysis of three different types of fatigue management interventions for people with multiple sclerosis: exercise, education, and medication. Mult Scler Int (2014) 0.93
Mindfulness-based interventions in multiple sclerosis: beneficial effects of Tai Chi on balance, coordination, fatigue and depression. BMC Neurol (2014) 0.91
Getting the balance right: a randomised controlled trial of physiotherapy and Exercise Interventions for ambulatory people with multiple sclerosis. BMC Neurol (2009) 0.91
Improving health outcomes with better patient understanding and education. Risk Manag Healthc Policy (2010) 0.91
Effect of combination exercise therapy on walking distance, postural balance, fatigue and quality of life in multiple sclerosis patients: a clinical trial study. Iran Red Crescent Med J (2014) 0.90
The Canadian survey of health, lifestyle and ageing with multiple sclerosis: methodology and initial results. BMJ Open (2014) 0.89
Exercise in multiple sclerosis -- an integral component of disease management. EPMA J (2011) 0.87
The role of exercise in modifying outcomes for people with multiple sclerosis: a randomized trial. BMC Neurol (2013) 0.87
Adaptive robot training for the treatment of incoordination in Multiple Sclerosis. J Neuroeng Rehabil (2010) 0.87
Fatigue and physical disability in patients with multiple sclerosis: a structural equation modeling approach. J Behav Med (2010) 0.85
Hydrotherapy for the treatment of pain in people with multiple sclerosis: a randomized controlled trial. Evid Based Complement Alternat Med (2011) 0.85
The treatment of fatigue. Neurol Sci (2008) 0.85
Treadmill training in multiple sclerosis: can body weight support or robot assistance provide added value? A systematic review. Mult Scler Int (2012) 0.85
Exercise therapy and multiple sclerosis: a systematic review. J Neurol (2013) 0.84
Assessment of gait parameters and fatigue in MS patients during inpatient rehabilitation: a pilot trial. J Neurol (2010) 0.83
Bone loss and fractures in multiple sclerosis: focus on epidemiologic and physiopathological features. Int J Gen Med (2011) 0.83
Physical activity and associated levels of disability and quality of life in people with multiple sclerosis: a large international survey. BMC Neurol (2014) 0.83
Management of fatigue in persons with multiple sclerosis. Front Neurol (2014) 0.83
Meta-analysis of quality-of-life outcomes from physical activity interventions. Nurs Res (2009) 0.83
Walking impairment in patients with multiple sclerosis: exercise training as a treatment option. Neuropsychiatr Dis Treat (2010) 0.83
Physical activity in subjects with multiple sclerosis with focus on gender differences: a survey. BMC Neurol (2014) 0.82
Fatigue in neuromuscular disorders: focus on Guillain-Barré syndrome and Pompe disease. Cell Mol Life Sci (2010) 0.82
Emerging evidence-based physical rehabilitation for multiple sclerosis - towards an inventory of current content across Europe. Health Qual Life Outcomes (2010) 0.81
The effects of a twelve-week home walking program on cardiovascular parameters and fatigue perception of individuals with multiple sclerosis: a pilot study. Cardiopulm Phys Ther J (2009) 0.81
Benefits of whole-body vibration with an oscillating platform for people with multiple sclerosis: a systematic review. Mult Scler Int (2012) 0.81
Associations of Lifestyle, Medication, and Socio-Demographic Factors with Disability in People with Multiple Sclerosis: An International Cross-Sectional Study. PLoS One (2016) 0.81
Impact of a 10-week individualized exercise program on physical function and fatigue of people with multiple sclerosis: a pilot study. Int J MS Care (2011) 0.80
The Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigue. EPMA J (2016) 0.79
Improving physical functional and quality of life in older adults with multiple sclerosis via a DVD-delivered exercise intervention: a study protocol. BMJ Open (2014) 0.79
A task-oriented circuit training in multiple sclerosis: a feasibility study. BMC Neurol (2014) 0.78
Predictors of exercise participation in ambulatory and non-ambulatory older people with multiple sclerosis. PeerJ (2015) 0.78
Effect of high-dose vitamin D3 intake on ambulation, muscular pain and bone mineral density in a woman with multiple sclerosis: a 10-year longitudinal case report. Int J Mol Sci (2012) 0.78
Rehabilitation interventions for the management of multiple sclerosis relapse: a short scoping review. Int J MS Care (2014) 0.78
Community neurorehabilitation: a synthesis of current evidence and future research directions. NeuroRx (2006) 0.78
Attitude towards physical activity in patients with multiple sclerosis: a cohort study. Neurol Sci (2015) 0.77
Effectiveness of multi-disciplinary rehabilitation for patients with Neuromyelitis Optica. J Spinal Cord Med (2016) 0.76
Body composition in multiple sclerosis. Hippokratia (2013) 0.76
Rhythmic cued motor imagery and walking in people with multiple sclerosis: a randomised controlled feasibility study. Pilot Feasibility Stud (2015) 0.75
Feasibility and Impact of an 8-Week Integrative Yoga Program in People with Moderate Multiple Sclerosis-Related Disability: A Pilot Study. Int J MS Care (2017) 0.75
Improving outcomes in multiple sclerosis through early diagnosis and effective management. Prim Care Companion CNS Disord (2012) 0.75
Study protocol: to investigate effects of highly specialized rehabilitation for patients with multiple sclerosis. A randomized controlled trial of a personalized, multidisciplinary intervention. BMC Health Serv Res (2012) 0.75
Perceptions of Participants in a Group, Community, Exercise Programme for People with Multiple Sclerosis. Rehabil Res Pract (2015) 0.75
Reliability and responsiveness of cardiopulmonary exercise testing in fatigued persons with multiple sclerosis and low to mild disability. PLoS One (2015) 0.75
Aerobic exercise in people with multiple sclerosis: its feasibility and secondary benefits. Int J MS Care (2013) 0.75
A pilot study of an exercise-based patient education program in people with multiple sclerosis. Mult Scler Int (2014) 0.75
What Does the Cochrane Collaboration Say about Cardiovascular Training? Physiother Can (2008) 0.75
A combined exercise model for improving muscle strength, balance, walking distance, and motor agility in multiple sclerosis patients: A randomized clinical trial. Iran J Neurol (2016) 0.75
Critical Appraisal of Evidence for Improving Gait Speed in People with Multiple Sclerosis: Dalfampridine Versus Gait Training. Int J MS Care (2016) 0.75
Clinical implications of neuroplasticity - the role of rehabilitation in multiple sclerosis. Front Neurol (2015) 0.75
Changes of Motivational Variables in Patients with Multiple Sclerosis in an Exercise Intervention: Associations between Physical Performance and Motivational Determinants. Behav Neurol (2015) 0.75
Uhthoff`s phenomenon 125 years later - what do we know today? J Med Life (2016) 0.75
Outcome expectations and physical activity in persons with longstanding multiple sclerosis. J Neurosci Nurs (2014) 0.75
Effects of a Short Physical Exercise Intervention on Patients with Multiple Sclerosis (MS). Int J Mol Sci (2015) 0.75
Mii-vitaliSe: a pilot randomised controlled trial of a home gaming system (Nintendo Wii) to increase activity levels, vitality and well-being in people with multiple sclerosis. BMJ Open (2017) 0.75
Neurorehabilitation: applied neuroplasticity. J Neurol (2016) 0.75
Effect of aerobic interval training on serum IL-10, TNFα, and adipokines levels in women with multiple sclerosis: possible relations with fatigue and quality of life. Endocrine (2017) 0.75
Do Patients with Multiple Sclerosis Derive More Benefit from Robot-Assisted Gait Training Compared with Conventional Walking Therapy on Motor Function? A Meta-analysis. Front Neurol (2017) 0.75
Exercise prescription for patients with multiple sclerosis; potential benefits and practical recommendations. BMC Neurol (2017) 0.75
[Multiple sclerosis : rehabilitation and long-term course]. Ophthalmologe (2014) 0.75
Regulation of the bacterial cell wall: analysis of a mutant of Bacillus subtilis defective in biosynthesis of teichoic acid. J Bacteriol (1972) 5.55
Core assessment program for intracerebral transplantations (CAPIT). Mov Disord (1992) 5.51
American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001--testing for early lung cancer detection. CA Cancer J Clin (2001) 4.41
Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency. Neurology (2010) 3.98
Cueing training in the home improves gait-related mobility in Parkinson's disease: the RESCUE trial. J Neurol Neurosurg Psychiatry (2007) 3.60
Asia Pacific consensus recommendations for colorectal cancer screening. Gut (2008) 3.19
A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest (2001) 3.18
The impact of physical therapy on functional outcomes after stroke: what's the evidence? Clin Rehabil (2004) 3.14
Postwithdrawal rebound increase in T2 lesional activity in natalizumab-treated MS patients. Neurology (2007) 2.88
Safety, tolerability, and efficacy of orally administered cannabinoids in MS. Neurology (2002) 2.36
Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group. J Pain Symptom Manage (1997) 2.29
Risk of fractures in patients with multiple sclerosis: a population-based cohort study. Neurology (2012) 2.25
Arsenic and mercury intoxication due to Indian ethnic remedies. BMJ (1993) 2.24
Pathogenesis of the urethral syndrome in women and its diagnosis in general practice. Lancet (1972) 2.21
Training with inspiratory pressure support in patients with severe COPD. Eur Respir J (2006) 2.18
Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI. Neurology (2011) 2.17
Ibudilast in relapsing-remitting multiple sclerosis: a neuroprotectant? Neurology (2010) 2.03
Clinical impact of 20% worsening on Timed 25-foot Walk and 9-hole Peg Test in multiple sclerosis. Mult Scler (2006) 1.99
Effects of external rhythmical cueing on gait in patients with Parkinson's disease: a systematic review. Clin Rehabil (2005) 1.91
Spontaneous MxA mRNA level predicts relapses in patients with recently diagnosed MS. Neurology (2010) 1.88
Impact of inspiratory muscle training in patients with COPD: what is the evidence? Eur Respir J (2011) 1.80
The management of suspected urinary tract infection in general practice. Br J Gen Pract (1990) 1.76
Responsiveness and predictive value of EDSS and MSFC in primary progressive MS. Neurology (2008) 1.62
The effects of physical therapy in Parkinson's disease: a research synthesis. Arch Phys Med Rehabil (2001) 1.62
Preliminary report on isolation of mycobacteria from patients with Crohn's disease. Dig Dis Sci (1989) 1.60
Trends in the epidemiology of COPD in Canada, 1980 to 1995. COPD and Rehabilitation Committee of the Canadian Thoracic Society. Chest (1999) 1.59
Towards the reality of the primary health care team: an educational approach. J R Coll Gen Pract (1981) 1.57
Surgical treatment options for carpal tunnel syndrome. Cochrane Database Syst Rev (2007) 1.53
EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease. Eur J Neurol (2013) 1.52
Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann Neurol (1994) 1.50
Symptomatic urinary infection in childhood: presentation during a four-year study in general practice and significance and outcome at seven years. J R Coll Gen Pract (1977) 1.47
MR spectroscopic evidence for glial increase but not for neuro-axonal damage in MS normal-appearing white matter. Magn Reson Med (2005) 1.42
Should the endurance shuttle walk test replace the six-minute walk test in individuals with chronic obstructive pulmonary disease? Chron Respir Dis (2006) 1.41
The INTERMED: a screening instrument to identify multiple sclerosis patients in need of multidisciplinary treatment. J Neurol Neurosurg Psychiatry (2003) 1.41
Internal fixation of wrist fractures. J R Soc Med (1978) 1.39
A systematic review of Instrumental Activities of Daily Living scales in dementia: room for improvement. J Neurol Neurosurg Psychiatry (2009) 1.39
Transgenic plants as factories for biopharmaceuticals. Nat Biotechnol (2000) 1.39
Statement on withholding and withdrawing life-sustaining therapy. S Afr Med J (1994) 1.38
Pharmacokinetic properties of several novel oligonucleotide analogs in mice. J Pharmacol Exp Ther (1996) 1.38
Measuring gait and gait-related activities in Parkinson's patients own home environment: a reliability, responsiveness and feasibility study. Parkinsonism Relat Disord (2005) 1.38
Interobserver variability in the radiological assessment of response to chemotherapy in glioma. Neurology (2003) 1.35
Causes of death in patients with multiple sclerosis and matched referent subjects: a population-based cohort study. Eur J Neurol (2012) 1.29
Chemically modified oligonucleotides exhibit decreased immune stimulation in mice. J Pharmacol Exp Ther (2000) 1.28
Who uses the Smoker's Quitline in Massachusetts? Tob Control (2002) 1.27
Rehabilitation, exercise therapy and music in patients with Parkinson's disease: a meta-analysis of the effects of music-based movement therapy on walking ability, balance and quality of life. Parkinsonism Relat Disord (2012) 1.26
Is fatigue an independent factor associated with activities of daily living, instrumental activities of daily living and health-related quality of life in chronic stroke? Cerebrovasc Dis (2006) 1.25
The use of rhythmic auditory cues to influence gait in patients with Parkinson's disease, the differential effect for freezers and non-freezers, an explorative study. Disabil Rehabil (2006) 1.24
Pressure-volume index in head injury. J Neurosurg (1987) 1.23
Diagnostic value of high-resolution sonography in ulnar neuropathy at the elbow. Neurology (2004) 1.23
Inter-observer variability of the EEG diagnosis of seizures in comatose patients. Seizure (2008) 1.19
Immediate effects of arousal from sleep on cardiac autonomic outflow in the absence of breathing in dogs. J Appl Physiol (1985) (1995) 1.18
Nutritional support for individuals with COPD: a meta-analysis. Chest (2000) 1.16
Effects of controlled inspiratory muscle training in patients with COPD: a meta-analysis. Eur Respir J (2002) 1.15
Impairments in balance discriminate fallers from non-fallers in COPD. Respir Med (2009) 1.14
Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations. Brain (2002) 1.13
Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). An intermediate clinical phenotype caused by substitution of valine for glycine at position 137 of arylsulfatase B. J Biol Chem (1991) 1.13
A lipid intermediate in the synthesis of a poly-(N-acetylglucosamine 1-phosphate) from the wall of Staphylococcus lactis N.C.T.C. 2102. Biochem J (1969) 1.12
A specific molar ratio of stabilizer to protein is required for storage stability of a lyophilized monoclonal antibody. J Pharm Sci (2001) 1.12
Direction of chain extension during the biosynthesis of teichoic acids in bacterial cell walls. Nature (1969) 1.12
The mechanism of biosynthesis and direction of chain extension of a poly-(N-acetylglucosamine 1-phosphate) from the walls of Staphylococcus lactis N.C.T.C. 2102. Biochem J (1969) 1.10
Predictive value of ischemic lesion volume assessed with magnetic resonance imaging for neurological deficits and functional outcome poststroke: A critical review of the literature. Neurorehabil Neural Repair (2006) 1.10
Glucosylation of teichoic acid: solubilization and partial characterization of the uridine diphosphoglucose: polyglycerolteichoic acid glucosyl transferase from membranes of Bacillus subtilis. J Bacteriol (1971) 1.10
Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study. J Neurol Neurosurg Psychiatry (2005) 1.07
Oxygen therapy during exercise training in chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2007) 1.06
Role of endoscopic retrograde cholangiopancreatography for suspected choledocholithiasis in patients undergoing laparoscopic cholecystectomy. Gastrointest Endosc (1998) 1.06
One year changes in disability in multiple sclerosis: neurological examination compared with patient self report. J Neurol Neurosurg Psychiatry (2003) 1.06
The effects of visual rhythms and optic flow on stride patterns of patients with Parkinson's disease. Parkinsonism Relat Disord (2005) 1.06
Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability. Mult Scler (2004) 1.05
Sulphadimidine, co-trimoxazole, and a placebo in the management of symptomatic urinary tract infection in general practice. J R Coll Gen Pract (1972) 1.04
Perspectives that influence action plans for chronic obstructive pulmonary disease. Can Respir J (2006) 1.04
Electrokinetic and electrostatic properties of bilayers containing gangliosides GM1, GD1a, or GT1. Comparison with a nonlinear theory. Biophys J (1986) 1.03
Acute and chronic effects of airway obstruction on canine left ventricular performance. Am J Respir Crit Care Med (1999) 1.03
CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis. Neurology (2004) 1.03
The effect of rhythmic somatosensory cueing on gait in patients with Parkinson's disease. J Neurol Sci (2006) 1.03
The attentional cost of external rhythmical cues and their impact on gait in Parkinson's disease: effect of cue modality and task complexity. J Neural Transm (Vienna) (2007) 1.03
Everyday walking with Parkinson's disease: understanding personal challenges and strategies. Disabil Rehabil (2008) 1.02
Enzyme immunoassay for surveillance of Q fever. Am J Vet Res (1985) 1.01
Surgical treatment options for carpal tunnel syndrome. Cochrane Database Syst Rev (2004) 1.00
Psychometric evaluation of the multiple sclerosis impact scale (MSIS-29) for proxy use. J Neurol Neurosurg Psychiatry (2005) 0.99
Evidence for additional genetic risk indicators of relapse-onset MS within the HLA region. Neurology (2002) 0.99
The development of a clinical practice stroke guideline for physiotherapists in The Netherlands: a systematic review of available evidence. Disabil Rehabil (2007) 0.98
PET: its clinical role in neurology. J Neurol Neurosurg Psychiatry (1991) 0.98
APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers. Neurology (2006) 0.97
Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis. Neuroradiology (2010) 0.97
Multiple sclerosis: Neurofilament light chain antibodies are correlated to cerebral atrophy. Neurology (2003) 0.97
Home telemonitoring effectiveness in COPD: a systematic review. Int J Clin Pract (2014) 0.96
Brain atrophy and lesion load as explaining parameters for cognitive impairment in multiple sclerosis. Mult Scler (2005) 0.96
Seasonal variation in immune measurements and MRI markers of disease activity in MS. Neurology (2002) 0.96
Ventilatory and arousal responses to hypoxia and hypercapnia in a canine model of obstructive sleep apnea. Am J Respir Crit Care Med (1997) 0.96
In vitro investigation of autoantibody-secreting peritoneal cells and their regulation. Immunology (1979) 0.96
The reactivity of a monoclonal antibody against cells of the monocyte-macrophage series in sections of normal and inflamed human tissues. J Reticuloendothel Soc (1983) 0.96
Respiratory-related heart rate variability persists during central apnea in dogs: mechanisms and implications. J Appl Physiol (1985) (1995) 0.95
Clinical correlations of brain lesion distribution in multiple sclerosis. J Magn Reson Imaging (2009) 0.95
Chest physical therapy management of patients with cystic fibrosis. A meta-analysis. Am J Respir Crit Care Med (1995) 0.95
The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients. Chest (1998) 0.95
Nutritional supplementation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2005) 0.95
Critical appraisal of clinical practice guidelines targeting chronic obstructive pulmonary disease. Arch Intern Med (2001) 0.95
Eosinophilic cholangiopathy. Gastrointest Endosc (1997) 0.95
Race and child welfare services: past research and future directions. Child Welfare (1997) 0.95